Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Crou, It takes almost 2 minutes to open a message at IV. I am here until the speed picks up. On the subject of paid memberships at IV. I scanned some other boards and alot of people have paid. I really hate to leave IV mainly because of the moderator system on Ihub. Do you think we get any revelations from the R&R today?
You obviously have no clue what your talking about.
Yes he did. The call was to give updates on several programs
at Cleveland Clinic that followed up a whole day of analyst
meetings with trial docs. It just so happens that the only PI
he didn't give the name of was the one who gave him the
Provenge quote. The call was disturbing.
Dew, did you get a chance to listen to the Lazard Cleveland
clinic call. Joel Sendek is a complete idiot. If you did
how could you not think the DNDN folks have a slight right to
be upset. This is a quote from Sendek straight from the call
"Lead PI said that Provenge effect was a hallucination and
same Doc says Abiraterone is the holy grail." Sendek's
questions on all the calls I've heard him on are quite
simple and he seems to lack a very basic knowledge of anything
needed for an adequate biotech analyst. He has been corrected
on calls several times by DNDN management and on many other
CC he has participated in.
No absolutely not. I hope it is a great drug. His hand in
everything PCa is bad for the science. He made a huge
mistake with the Asentar trial dosing and I don't think
he has the best interests of patients at heart. At one time
last year he was the lead investigator on 3 very high profile
PCa drug trials. One man controlling everything is not good.
If the IV board is so unappealing why do you monitor it so
closely. You would have to be a complete idiot to not
understand Howard Scher's dislike of Provenge. You could see
it at the AC panel. Total hatred. Did you also know that
Medivation has ties to Proquest investments? No I'm not a
conspiracy theorist but when it hits you over the head
sometimes you have to pay attention. Back to Howard Scher,
if DNDN succeeds they will be the big player in PCa. I know
you don't think ego has nothing to do with this. Ego has
everything to do with it. To be the big dog in a field is
a very big thing. Disclosure: very long DNDN. Just to let
you know I believe a close result will get them approval with
a deal that was struck 2 years ago this May...GLTU and I enjoy
your board.
This was extended a while back so it doesn't expire this week............
"featuring the FDA ruling". You obviously don't know what you are talking about. It is a poster presentation. Has nothing to do with the FDA.
I have always (last 4 years) believed it works...watch today
DNDN to present Provenge results at AUA April 28th 2009
DNDN to present Provenge results at AUA April 28th 2009
I wouldn't short a stock whose Pharmacies fill 17 out of every 100 prescriptions filled each day in the United States. Actually that number will be a little better after we post this quarters financials. That being CVS. GLTU
Why didn't you like working for Walgreens? Just curious.
Does anyone here have a position in Resverlogix? If you do or don't and have an opinion I'd appreciate it. I have held the stock for quite a while and would like some input. Do you think a deal is still likely? Any kind of discussion would be apprecitated. TIA
So you don't believe DNDN knows what they did? Do you know the biostatitician personally or is that just an opinion? Did you listen to the call today? I think they understand it very well after listening to the call. Almost everyone got this wrong yesterday..even BSR..they had to put out a second alert. I am more confident in my investment now than before the call. I think your statement is rather harsh. JMHO
Dendreon to present at ASCO Feb. 14th...just posted on IV.
I own ZGEN and DNDN and I think this guy is the most crooked analyst on wallstreet. How he keeps a job is amazing. The manipulation in ZGEN stock yesterday was sickening. If you own it hold for 12 months and you will be happy..I hope..Where is the SEC?
You're kidding right..It doesn't mean it will be approved but if there was a conspiracy to give a CR instead of approval letter you can bet your ass something will happen...how can someone be that negative on this developemtn after all that happened after AC.
They don't have to review the BLA it was rec'd for approval. Remember. The saga that happened after the AC is what will be investigated.
What are the chances we have a positive announcement about trp-p8 in the near future? Gold's tone seemed quite upbeat when he spoke about it at the conference call. Hasn't it been over 2 years since any press was put out about it?
9902b enrollment completed..clinicaltrials.gov has it closed as of today..